Showing results (1111-1120 of 1,216) with videos related to

Sort By:
Pageof 122
International Journal of Cardiology|July 5, 2021
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-upViviana Maestrini, Lucia Ilaria Birtolo, Marco Francone, et al.
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
Antioxidants (Basel, Switzerland)|March 28, 2026
Novel Insights on Benzo[b]thiophene Analogues for MAO-B Inhibition and Neuroprotection: Design, Synthesis, Molecular Modelling Studies and Biological ActivityFrancesca Arrighi, Emanuela Berrino, Paolo Guglielmi, et al.
Kidney International Reports|February 18, 2026
Dapagliflozin in Patients With CKD With Fabry DiseaseYuri Battaglia, Nicola Vitturi, Giacomo Marchi, et al.
International Journal of Molecular Sciences|October 14, 2023
Osteoimmunology of SpondyloarthritisAngelo Fassio, Fabiola Atzeni, Maurizio Rossini, et al.
Journal of Clinical Pathology|October 5, 2006
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of CancerChalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
Leukemia|September 25, 2024
MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunityJustus M Huelse, Swati S Bhasin, Kristen M Jacobsen, et al.
Physical Therapy|August 29, 2022
The Fibromyalgia Transcutaneous Electrical Nerve Stimulation in Physical Therapy Study Protocol: A Multisite Embedded Pragmatic TrialAndrew A Post, Dana L Dailey, Emine O Bayman, et al.
Plos One|May 16, 2019
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experienceAlessandra Mangia, Valeria Piazzolla, Anna Giannelli, et al.
Clinical and Experimental Rheumatology|October 19, 2021
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre studyLuca Navarini, Damiano Currado, Francesco Caso, et al.
Pageof 122